23 Jan Carisma Therapeutics
Posted at 17:24h
in
Tom Wilton, Chief Business Officer
April 9 | 2:45pm | Salone dei Cavalieri, Section 2
Philadelphia, PA
(NASDAQ: CARM)
Carisma Therapeutics is a clinical stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response.
